Newsletter | MedInvest Life Science Conference

Manna Villafana, Co-Founder St. Jude Medical, Speaks on Development of Pacemaker

Watch

Dr. Robert Gallo Speaks About Re-Purposing Polio Vaccine in the War Against COVID-19

Dr. George Poste on Biosecurity: A Multi-Dimensional Challenge of Escalating Complexity and Urgency

Dr. Alfred Slanetz: Developing Cellular Therapies for COVID-19

Recent Articles

INNOVO Seeking Participation in Series C for Groundbreaking Female SUI Treatment

INNOVO ® (www.myinnovo.com) is an FDA-Approved, CE-marked treatment for women suffering from Stress Urinary Incontinence. It works by...

Automating Shoulder Care and Upper Body Rehab with Data-Driven Robotics

Harmonic Bionics, led by a highly talented and successful leadership team with vast medical device experience, is a commercial-stage...

Nutromics: Saving Lives through Continuous Diagnostic Monitoring

Every minute counts when treating a patient with a rapidly changing and unstable condition. Currently, the best way for clinicians to...

What’s Missing from Cancer Treatment? YOU!

Current State of Cancer Cancer treatment protocols have been built over time from lots of people, lots of data, using identified drugs...

MedInvest to Host Its MedTech, AI & Digital Health Conference Virtually on September 28-29, 2022

MedInvest will host its annual MedTech, AI, and Digital Health Conference virtually this year on Wednesday, September 28 and Thursday,...

Dr. Christopher Schlenger, Inventor & Founder of Verdure Imaging, Joining the Ultrasound Revolution

Verdure Imaging has developed software that takes the images produced by ultrasound, maps them to the body and in real time produces a 3D...

Transforming Healthcare: Improving the Patient Experience Via a Novel Cardiac Analysis Platform

An Unwavering Commitment to Patients Despite decades of research and progress, cardiovascular disease remains one of the leading causes...

SciTech Set to Advance ST-001 nanoFenretinide to Clinical Trials

The well-studied, promising anticancer drug, fenretinide, first developed by Johnson and Johnson, prepares to advance into an accelerated...

Radiopharm Theranostics: Innovating the Way We See and Treat Cancer

Radiopharm Theranostics is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical...

The Promise of mRNA Therapeutics in Producing the First Regenerative Treatment for SUI

Stress Urinary Incontinence (SUI) affects up to 50% of women across the globe at some point in their lifetime and is a major problem in a...

Lixte's LB-100, Protein Phosphatase 2A (PP2A) Inhibitor, Enters Phase 1b/2 Studies

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) is a clinical stage pharmaceutical company focused on identifying new targets for...

MediSieve: A Biotech Platform for Patients, Clinicians and Pharma

MediSieve is a Biotech that has developed an exciting new platform technology that can provide benefits to patients, doctors and...

Repair Biotechnologies, a Longevity Industry Company Tackling the Greatest Cause of Human Mortality

Reason and Bill Cherman founded Repair Biotechnologies in 2018, a company now among perhaps 100 or more preclinical biotech startups...

MedInvest Biopharmaceutical and Biotechnology Conference

MedInvest will be hosting its Pharmaceutical and Biotechnology Conference on March 30 and 31, 2022. The event will feature a live stream...

Minerva: Targeting MUC1

Minerva Biotechnologies is a privately held clinical-stage company with a near-term pipeline protected by an IP fortress. You may not...

Patia: Pioneering the prevention of a silent Pandemia

A silent pandemia is affecting Four Hundred Million People worldwide. You may call it Sugar, others call it Type Two Diabetes T2D. A...

Travel Telemed – The New Travel Essential for a Post-Covid World

Travel Telemed is a joint venture between an international commercial airline, two billion-dollar international development and...

Intrommune: Focused on Food Allergy Immunotherapy

Intrommune Therapeutics, Inc. is a New York City-based clinical stage biotechnology company dedicated to simplifying allergy...

Moderna and Pfizer to Start Phase III Trial for COVID-19 Vaccine

Moderna (MRNA) announced on Monday, July 27 that it had begun Phase III trials for its COVID-19 vaccine, a day following another...

Geneius Advances A T-Cell Vaccine and Therapy Product for SARS-CoV-2

Geneius Biotechnology, Inc, a Massachusetts-based biopharmaceutical company, announced at the MedInvest Infectious Disease & Immunology...

View Additional Video Content Here

Manna Villafana, Co-Founder St. Jude Medical, Speaks on Development of Pacemaker

Recent Video Content

Recent Articles

View Additional Video Content Here